return to news
  1. Namita Thapar's Emcure Pharmaceuticals IPO - Key insights & details

Market News

Namita Thapar's Emcure Pharmaceuticals IPO - Key insights & details

Gauri Singh

4m 34s | Updated on July 02, 2024, 13:20 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Emcure Pharmaceuticals, India's 13th largest pharma company by domestic sales, plans an IPO from July 3-5, 2024. The ₹1,952.03 crore issue includes ₹800 crore fresh issue and ₹1,152.03 crore offer for sale, mainly for debt repayment.

Emcure Pharmaceuticals, incorporated in 1981, develops, manufactures and markets a wide range of pharma products. In this video, we cover details about the company and its IPO!

About The Author

Gauri Singh
Gauri Singh is an anchor and journalist with over a decade of experience, currently covering business, finance and general news. Beyond her professional pursuits as a storyteller, she is a cricket fan, loves travelling and is a dedicated yoga practitioner.

Next Story